Certified by Founder Lodge
SR One Capital Management
United States - San Francisco, CA
INVESTOR
1 Disclosed Funding Rounds $200,000,000
9 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
SR One Capital Management is a transatlantic biotech venture capital firm that seeks to partner with who we believe to be top entrepreneurs, scientists and investment partners in an effort to
| Company | Date | Round | Raised |
|---|---|---|---|
 Avenzo Therapeutics |
September, 23 ,2025 | Series B | $60,000,000 |
 ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
 Fore Biotherapeutics |
August, 25 ,2023 | Series D | $75,000,000 |
 Crystalys Therapeutics |
October, 01 ,2025 | Series A | $205,000,000 |
 Avalyn Pharma Inc. |
September, 28 ,2023 | Series C | $175,000,000 |
 Odyssey Therapeutics |
December, 06 ,2023 | Series C | $101,000,000 |
 Mission Therapeutics |
March, 15 ,2024 | Unknown | $32,101,650 |
| Avenzo Therapeutics |
September, 23 ,2025 | Series B | $60,000,000 |
| Crystalys Therapeutics |
October, 01 ,2025 | Series A | $205,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
